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Acoustic trauma is the most common cause of hearing loss and tinnitus in humans.
However, the impact of acoustic trauma on system biology is not fully understood. It
has been increasingly recognized that tinnitus caused by acoustic trauma is unlikely
to be generated by a single pathological source, but rather a complex network of
changes involving not only the auditory system but also systems related to memory,
emotion and stress. One obvious and significant gap in tinnitus research is a lack of
biomarkers that reflect the consequences of this interactive “tinnitus-causing” network.
In this study, we made the first attempt to analyse brain metabolic changes in rats
following acoustic trauma using metabolomics, as a pilot study prior to directly linking
metabolic changes to tinnitus. Metabolites in 12 different brain regions collected from
either sham or acoustic trauma animals were profiled using a gas chromatography
mass spectrometry (GC/MS)-basedmetabolomics platform. After deconvolution of mass
spectra and identification of the molecules, the metabolomic data were processed using
multivariate statistical analysis. Principal component analysis showed that metabolic
patterns varied among different brain regions; however, brain regions with similar
functions had a similar metabolite composition. Acoustic trauma did not change the
metabolite clusters in these regions. When analyzed within each brain region using the
orthogonal projection to latent structures discriminant analysis sub-model, 17 molecules
showed distinct separation between control and acoustic trauma groups in the auditory
cortex, inferior colliculus, superior colliculus, vestibular nucleus complex (VNC), and
cerebellum. Further metabolic pathway impact analysis and the enrichment overview
with network analysis suggested the primary involvement of amino acid metabolism,
including the alanine, aspartate and glutamate metabolic pathways, the arginine and
proline metabolic pathways and the purine metabolic pathway. Our results provide
the first metabolomics evidence that acoustic trauma can induce changes in multiple
metabolic pathways. This pilot study also suggests that the metabolomic approach has
the potential to identify acoustic trauma-specific metabolic shifts in future studies where
metabolic changes are correlated with the animal’s tinnitus status.
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INTRODUCTION
Acoustic trauma is the most common cause of hearing loss and
tinnitus in humans (Cooper, 1994). In fact, noise exposure is
the most frequently reported cause of occupational disorders
in the world (Nelson et al., 2005; Dobie, 2008) and the fourth
leading cause of medical referral for combatants returning
from deployment (Schulz, 2004). Therefore, the consequences of
exposure to acoustic trauma will impose a significant negative
economic burden on healthcare systems worldwide. Using
tinnitus as an example, this phantom sound is severe enough
in 1% of adults to affect their day-to-day normal life (Vio and
Holme, 2005). In severe cases, it can be extremely disturbing,
and even lead to suicide (Shargorodsky et al., 2010). In the
USA, tinnitus affects 25% of the population at some stage in
their life, with 8% of people experiencing persistent or chronic
tinnitus (Shargorodsky et al., 2010), and this is similar to
the prevalence for the rest of the world (Henry et al., 2005;
McCormack et al., 2014; Wu et al., 2015). While the prevalence of
tinnitus normally increases with age, noise exposure is believed
to be the most common cause of tinnitus in humans (Cooper,
1994).The prevalence of tinnitus is increased by several-fold
among military populations, especially those who have served
in battle zones (Shah et al., 2014). A recent study analyzed the
incidence of hearing loss and tinnitus in a group of people who
work in a noisy environment and found that approximately 40%
of them had tinnitus (Hong et al., 2016). It is also alarming
that an increasing number of adolescents and young adults
are experiencing tinnitus due to risky music-listening behaviors
(Vogel et al., 2014).
Tinnitus treatment options are very limited and none
of the currently available approaches, such as hearing aids,
sound masking, drug treatments, hyperbaric oxygen therapy,
acupuncture or neuromodulation, show benefit following meta-
analytic scrutiny (Hesser et al., 2011). There is no FDA-approved
drug marketed for tinnitus, but a wide variety of drugs have
been prescribed off-label with no added benefits (Langguth and
Elgoyhen, 2012). One of the reasons accounting for the lack of
effective treatment for tinnitus is its heterogeneity. First, there is
large etiologic heterogeneity in tinnitus. Tinnitus can be caused
by many factors including noise exposure, head and neck injury,
drug toxicity, ear infection, Meniere’s disease, aging and even
affective disorders, such as depression (see Baguley et al., 2013,
for a review), which suggests that the underlying mechanisms
of tinnitus can be very different for different causes. Second,
heterogeneity also exists in an individual’s reaction to tinnitus.
For example, tinnitus severity or tinnitus-related distress is not
always proportional to the loudness of the sound of the tinnitus,
but can be related to certain personality traits such as anxiety,
depression, sleeping difficulties and life satisfaction (Langenbach
et al., 2005; Langguth et al., 2007). Therefore, it is not surprising
that the outcomes of currently available tinnitus therapies are
highly variable (Hoare et al., 2011).
Traditionally, the gold standard, modern drug discovery
approach seeks to design more selective drugs with ideally
one specific target in order to reduce adverse side effects.
Despite excessive efforts and investment routinely made in
discovering individual molecular targets over the last two
decades, the rate of new drug candidates being translated to
clinical use is decreasing (Kola and Landis, 2004). Hopkins
(2008) argued that the “one gene, one drug, one disease” drug
design philosophy might be the fundamental problem. This is
because biological functions, or dysfunctions in disease status,
are more likely to be a consequence of complex biochemical
regulation processes driven by interactive networks within the
genome (Chen et al., 2008), transcriptome (Iancu et al., 2014),
proteome (Ebhardt et al., 2015), and metabolome (Shah et al.,
2015). Targeting such dynamic network biology by identifying
disease-causing networks rather than disease-causing genes, is
likely to be a more effective approach for drug discovery
(Roth et al., 2004; Hopkins, 2007, 2008; Kell and Goodacre,
2014).
Since genomics, epigenetics, transcriptomics, and proteomics
all converge at the level of metabolomics and changes in
metabolite concentrations are more substantial and defining
than signals in other “omics,” metabolomics is considered
to be the integration of all “omics.” Therefore, it is more
reliable, sensitive and powerful in reflecting changes in
biological functions due to either disease or drug action. By
systematically analyzing low molecular weight metabolites in
biological samples, metabolomics has been used to discover
new biomarkers for diagnosis, monitoring and understanding
the mechanisms of diseases and drugs in many areas, such as
cancer (Olivares et al., 2015), diabetes (Li et al., 2013), psychotic
disorders (Sethi and Brietzke, 2016), depression (Huang and Lin,
2015), cardiovascular diseases (Rankin et al., 2014), Alzheimer’s
disease (Graham et al., 2015), and epilepsy (Loeb, 2011).
In comparison, a significant gap in tinnitus research and drug
discovery is readily apparent. On the one hand, numerous studies
focus on one type of receptor, ion channel, neurotransmitter
or neuron in one area of the brain or one particular pathway
through molecular, electrophysiological and pharmacological
studies seeking to elucidate the underlying neural mechanisms to
cure tinnitus (Milbrandt et al., 2000; Liu et al., 2003; Eggermont
and Roberts, 2004; Brozoski et al., 2007, 2012; Kaltenbach
and Godfrey, 2008; Dong et al., 2010; Middleton et al., 2011;
Zhang et al., 2011; Richardson et al., 2012; Zheng et al., 2012;
Bauer et al., 2013; Kalappa et al., 2014). In contrast, advanced
neuroimaging technology reveals tinnitus-associated changes in
neuronal activity and connectivity involving multiple neural
networks, both in human patients (Leaver et al., 2011; Vanneste
et al., 2011; Kraus and Canlon, 2012; Maudoux et al., 2012; Song
et al., 2012; Vanneste and De Ridder, 2012; Boyen et al., 2014;
Husain and Schmidt, 2014) and an animal model (Chen et al.,
2014). It has been increasingly recognized by the international
tinnitus research community that tinnitus is unlikely to be
generated by a single pathological source, but rather by complex
network changes involving not only the auditory system but also
systems related to memory, emotion and stress (see Roberts et al.,
2010; Henry et al., 2014; Simonetti and Oiticica, 2015; Leaver
et al., 2016, for reviews). One obvious and significant gap is a
lack of biomarkers that reflect the consequences of this interactive
“tinnitus-causing” network. So far, only one study has attempted
to identify protein targets for tinnitus by analyzing the side effect
targets for 275 drugs that cause tinnitus (Elgoyhen et al., 2014).
Although this is the first study using a network approach to
Frontiers in Neuroscience | www.frontiersin.org 2 March 2017 | Volume 11 | Article 148
He et al. Metabolic Changes following Acoustic Trauma
identify targets related to tinnitus, the significance is limited by
the fact that tinnitus as a side effect may not necessarily be
generated through the drug’s pharmacological targets that were
analyzed in the study. Therefore, a more direct approach by
analyzing metabolite profiles in relation to tinnitus may provide
insights into the phenotype, underlying pathophysiology as well
as potential therapeutic targets of acoustic trauma and tinnitus.
In the present study, we made the first attempt in analyzing
metabolite profiles in different brain areas of rats at 6 months
after exposure to acoustic trauma. This was a pilot study in which
tissue from animals that had been subjected to acoustic trauma,
but no longer exhibited tinnitus-related behavior, was used to
investigate the potential application of metabolomics to the study
of the effects of acoustic trauma on the brain, with a view to its
potential relevance for tinnitus in the longer term.
METHODS
Animals and Tissue Sample Collection
The University of Otago Committee on Ethics in the Care
and Use of Laboratory Animals approved all experimental
procedures.
All the tissue samples were collected from our previous study
which investigated the effects of L-baclofen on acoustic trauma-
induced tinnitus (see Zheng et al., 2012, for details). Briefly, 16
male Wistar rats were divided into sham and acoustic trauma
groups (n = 8 per group) and tested for the behavioral signs
of tinnitus before receiving vehicle and 3 doses of L-baclofen
(1, 3, and 5 mg/kg). Following the last L-baclofen treatment (5
mg/kg), a 2-week washout period was allowed before the final
tinnitus behavioral testing (Zheng et al., 2012). At the end of
the final tinnitus testing, the animals were sacrificed and the
brains were rapidly removed, placed on ice and dissected into
12 different brain regions. These included the cochlear nucleus
(CN), vestibular nucleus complex (VNC), inferior colliculus (IC),
superior colliculus (SC), auditory cortex (AC), subregions of the
hippocampus [CA1, CA2/3 and dentate gyrus (DG)], frontal
cortex (FC), perirhinal cortex (PC), entorhinal cortex (ERC), and
cerebellum (CB). Dissections weremade according to the Paxinos
andWatson brain atlas (Paxinos andWatson, 2008). Tissues were
snap frozen on dry ice and kept at −80◦C until the time of the
assay.
Acoustic Trauma
Unilateral acoustic trauma was delivered using the procedure
described in Zheng et al. (2012). Animals were anesthetized with
ketamine HCl (75 mg/kg, s.c.) and medetomidine hydrochloride
(0.3 mg/kg, s.c.) and then placed inside a sound attenuation
chamber for a 1 h exposure to a 16 kHz 110 dB SPL pure tone
delivered to one of the ears (Zheng et al., 2012). The pure tone
was generated by an NI 4461 Dynamic Signal Acquisition and
Generation system (National Instruments New Zealand Ltd) and
was delivered to one of the ears through a closed field magnetic
speaker with a tapered tip (Tucker-Davis Technologies), attached
to a 3-mm cone-shaped speculum that was fitted tightly into
the external auditory canal. The sound pressures were calibrated
before noise exposure by connecting the speaker to a ¼-inch
prepolarized free-field microphone (Type 40BE, GRAS Sound,
and Vibration) via the speculum used to fit into the external
auditory canal. The unexposed ear was blocked with cone-shaped
foam and taped against the foam surface. The sham animals were
kept under anesthesia for the same duration as the noise trauma
animals, but without noise exposure.
Auditory Brainstem-Evoked Potentials
The auditory function of both ears of the exposed and sham
animals before and immediately after the acoustic trauma or
sham treatment was measured using auditory brainstem-evoked
response (ABR) thresholds, as described in Zheng et al. (2012).
Briefly, the animals were anesthetized as described in the Section
Acoustic Trauma and subdermal needle electrodes were placed
at the vertex and over the bullae with a reference electrode
at the occiput. ABR thresholds were tested for tone bursts (2
ms rise/decay, 1 ms plateau) presented at a rate of 50/s, in a
decreasing intensity series, beginning with levels that elicited
distinct evoked potentials. Hearing threshold was indicated by
the lowest intensity that produced visually distinct potentials.
Unilateral acoustic trauma produced an immediate elevation
of the ABR threshold in the exposed ear across all of the
frequencies tested (Zheng et al., 2012). However, the auditory
function of the ears of sham exposed animals and the unexposed
ears of the acoustic trauma exposed animals, were not affected.
Althoughwe did not test the animal’s ABR thresholds at 6months
post-exposure prior to sacrificing the animals in this study, we
reported in a separate study that ABR thresholds in the exposed
ear returned to the same level as that in sham animals at 6 months
after exposure (Zheng et al., 2015). This suggests that hearing loss
caused by the specific acoustic trauma we used is not permanent
and is most likely to subside by 6 months post-exposure.
Tinnitus Assessment
In the original study of Zheng et al. (2012), from which the tissue
used in this study was taken, the presence of tinnitus was tested
after the acoustic trauma using a conditioned lick suppression
paradigm, as described in detail in Zheng et al. (2012). Briefly,
tinnitus assessment was conducted in an operant conditioning
test chamber in which drinking activity was measured by a
lickometer with a photobeam. A speaker generated broadband
noise (BBN; white noise ranging from 3 to 20 kHz) or pure tones
of different frequencies and intensities via a sound generator.
The chamber floor delivered an electric shock produced by a
constant current shock source. The conditioned lick suppression
paradigm consisted of 15 min of testing daily and the animals
went through an acclimation phase, a Pavlovian conditioned
suppression training phase, and a frequency discrimination
phase. During the acclimation phase, the BBN was played
throughout the 15 min session except at 10 random intervals,
at which point 15 s acoustic stimuli were inserted. Two of the
10 presentations were always speaker off periods (i.e., silence)
and the remaining 8 were one of BBN, 10 kHz tones or 20 kHz
tones at one of 4 different intensity levels in a random order
with each stimulus repeated twice within each session. The type
of stimulus varied randomly between sessions, but remained
constant within a session. Following acclimation, each animal
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received conditioned suppression training in which a 3 s foot
shock (0.35 mA) was presented at the end of each speaker
off period. The foot shock acted as an unconditioned stimulus
(UCS) and the speaker off period acted as a conditioned stimulus
(CS). Over a few sessions, the rats reacted to the speaker off
by stopping licking (i.e., the conditioned suppression). Once
the lick suppression was established, the rats were subjected
to the frequency discrimination test, during which the acoustic
stimuli were presented in the same way as in the acclimation
and the suppression training. If a rat did not have tinnitus,
the presentation of the stimuli had no effect on its drinking
activity. However, if a rat had tinnitus, the tinnitus served as the
conditioned stimulus (CS) during the training sessions, therefore,
a stimulus with sensory features resembling tinnitus during the
testing session would produce greater suppression. Tinnitus was
assessed in these rats at 2 weeks after the noise exposure, during
the L-baclofen or vehicle treatment as well as at the end of the
experiment (Zheng et al., 2012).
Tissue Preparation
Frozen brain tissue samples were ground to an homogeneous
powder using a liquid nitrogen-chilled mortar and pestle and
rapidly transferred to a 1.5 mL microcentrifuge tube. Nine
hundredµl of methanol containing the internal standard, [13C2]-
myristic acid (12.5 µg/ml), was added to each tube. The mixture
was vigorously vortexed for 3 min and centrifuged at 20,000 g for
10 min at 4◦C.
An aliquot of 100 µl supernatant was transferred to a
gas chromatography (GC) vial and evaporated to dryness
using a SPD2010-230 SpeedVac Concentrator (Thermo Savant,
Holbrook, USA). The dried residue was then dissolved in 30µl of
methoxyamine in pyridine (10 mg/ml) and vigorously vortexed
for 2 min. The methoximation reaction was carried out for 16 h
at room temperature, followed by trimethylsilylation for 1 h by
adding 30 µl of N-methyl-N-(trimethylsilyl)trifluoroacetamide
(MSTFA) with 1% trimethylchlorosilane (TMCS) as the catalyst.
Finally, the solution was vortex-mixed again for 30 s after adding
the external standard, methyl myristate in heptane (30µg/ml), to
each GC vial for GC/mass spectrometry (MS) analysis.
GC/MS
Chromatographic separation of the analytes was achieved with
a Shimadzu GCMSQP2010 (Shimadzu Corp., Tokyo, Japan)
equipped with a RTx-5MS column (30 mm × 0.25 mm i.d.
fused-silica capillary column chemically bonded with a 0.25 µm
cross bond, 5% diphenyl/95% dimethyl polysiloxane, Restek
Corporation, PA, USA). Helium was used as the carrier gas and
the temperature was initially set at 80◦C for 3 min, which was
then increased to 300◦C at 20◦C/min. Once the temperature was
at 300◦C, it was maintained for another 3 min. The eluate was
introduced through the transfer line into the mass spectrometer,
where the molecules were ionized with a current beam of
70 eV. The masses were scanned over m/z 50–700 with a
detector voltage of −1050 V. To minimize systematic variations,
all samples were analyzed in a randomized order, and the
quantitative data were normalized to the internal standard. The
metabolites were identified by automatically comparing the MS
spectra, in-source fragments and ion features of each peak in the
experimental samples with those of reference standards or those
available in libraries, such as mainlib and publib in the National
Institute of Standards and Technology (NIST) library 2.0 (2012);
Wiley 9 (Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim,
Germany); the in-house mass spectra library database established
by Umeå Plant Science Center (Umeå University, Sweden) and
our own Laboratory at China Pharmaceutical University.
Data Analysis
Mean differences between the sham and acoustic trauma groups
were compared using two-sample independent Student’s t-tests.
However, since the metabolomics data have multiple dependent
variables, it required multivariate statistical analysis that takes
account of changes in systems of variables and would be sensitive
to changes that may occur at the system level between sham
and acoustic trauma animals. One approach to analyzing changes
in systems of variables is principal component analysis (PCA),
in which large numbers of variables (i.e., “high dimensional
data”) are reduced to components or eigenvalues that represent
combinations of variables that account for most of the variation
in the data (Manly, 2005). In PCA, these components also have
weightings or “eigenvectors” that indicate the weight of each
variable within a component. The different components are
intended to be independent of one another (“orthogonal”) so
that they capture unique aspects of the variation in the data.
PCA, unlike Factor Analysis, does not assume a formal statistical
model and therefore assumptions such as multivariate normality
are unnecessary. PCA was performed on the correlation matrix
(i.e., the data were z transformed) (Manly, 2005). Loading plots
were used to determine the clustering of variables and whether
their relationship within components changed as a result of
acoustic trauma. Another way of analyzing multivariate changes
is linear discriminant analysis (LDA), which attempts to identify
a linear equation that combines the metabolomics variables,
with different weightings, in order to predict whether animals
belong to the sham or acoustic trauma groups. Partial least
squares discriminant analysis (PLS-DA, equivalent to “projection
to latent structures DA”) is a method that uses partial least
squares regression in the discriminant analysis, which can be
used to elucidate the separation between groups of variables
through rotating the principal components obtained in PCA,
and is particularly useful when there are more variables than
observations and when there is correlation or “multicollinearity”
amongst the variables (Tang et al., 2014). In orthogonal
projection to latent structures DA (OPLS-DA), an extension
of PLS-DA, the data from the continuous variables in the
discriminant analysis function are separated into those that are
predictive of the dependent variable (e.g., sham or acoustic
trauma) and those that are not, resulting in enhanced diagnostics.
We performed OPLS-DA and then tested the efficacy of the
discriminant functions in predicting whether the animals were
exposed to acoustic trauma, using cross-validation (Manly, 2005).
The goodness of fit for a model was evaluated using three
quantitative parameters: i.e., R2X, the explained variation in
X, R2Y, the explained variation in Y, and Q2Y, the predicted
variation in Y based on the model using cross-validation
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(Sedghipour and Homayoun Sadeghi-Bazargani, 2012). The
range of these parameters is between 0 and 1; the closer they
approach 1, the better they can be predicted or explained. All
analyses were carried out using R (R Core Team, 2013). In formal
statistical tests, P ≤ 0.05 was considered significant. Variable
importance was used to summarize the importance of the X-
variables, both for the X- and Y-models and was measured
by the variable influence on projection (VIP). The VIP value
is a parameter indicating the importance of a variable that
contributes to the model. In a model, one can compare the VIP
of one variable to the others. Variables with a large VIP, larger
than 1, are the most relevant for explaining Y. The S-plot is an
easy way to visualize an OPLS discriminant analysis model of
two classes, since it provides visualization of the OPLS/OPLS-DA
predictive component loading to facilitate model interpretation
(Wiklund et al., 2008). The S-plot is used to visualize both the
covariance and the correlation structure between the X-variables
and the predictive score t[1]. Thus, the S-plot is a scatter plot
of the p[1] vs. p(corr)[1] vectors of the predictive component.
The axes in the S-plot from the predictive component are p1 and
p(corr)1, representing the magnitude (modeled covariation) and
reliability (modeled correlation), respectively. Hence, in the S-
plot both magnitude (intensity) and reliability are visualized. In
spectroscopic data, the magnitude of the peak is very important
as peaks with low magnitude are close to the noise level and thus
have a higher risk for spurious correlation. Ideally, biomarkers
would have both high reliability and magnitude. This plot often
takes the shape of the letter “S.” X-variables situated far out on
the wings of the S shape represent higher model influence with
higher reliability and are of relevance in the search for biomarkers
that are up- or down-regulated. In addition, metabolic pathway
analysis was performed by inputting discriminant molecules into
Metaboanalyst (available online at http://www.metaboanalyst.
ca) and network analysis was processed by Metscape 3.1-based
on Cytoscape 3.3.0. “Relative abundance” was calculated by
summing the integral areas of metabolites with high variable
importance scores, normalizing them, and comparing the sham
vs. acoustic trauma groups using a two-sample, independent
Student’s t-test (Gray et al., 2015).
RESULTS
GC/MS analysis of the brain tissue extracts revealed a
large number of peaks (Figure 1). Deconvolution of the
chromatograms produced a total of 107 distinct peaks and 88
were authentically identified by comparing the mass spectrum
of the peak with that available in the libraries and that of the
reference compounds. These included amino acids, small organic
acids, carbohydrates, fatty acids, lipids, and amines. To acquire
the quantitative data, a feature mass (m/z) was chosen for each
peak, and the peak area was obtained for each deconvoluted
peak/molecule.
A data matrix of molecules in samples from the sham and
acoustic trauma animals for the 12 brain areas was initially
analyzed using PCA and PLS-DA. PLS-DA score plots, in which
the scores for PC2 (i.e., t[2]) were plotted against those for PC1
(t[1]), were used to show the distribution of the analyzed samples
containing the information from all the metabolites in different
brain areas (Figure 2). According to the PLS-DA algorithm,
each dot represents the summarized information from all the
88 molecules measured in a single sample for a particular brain
region. Therefore, the distance between the dots indicates the
similarity of the metabolic composition between the samples, i.e.,
the closer they cluster together the more similar they are. An
overview of the PLS-DA score plot of the sham animals revealed
that the composition of metabolites varied between different
brain regions; however, brain regions with similar functions
seemed to have a similar metabolite composition (Figure 2A).
For example, metabolites from the temporal lobe area, such as the
CA1, CA2/3, DG, ERC, and PC, were located close to each other
on the PLS-DA score plots but were further apart from those from
midbrain and hindbrain areas. Animals that received acoustic
trauma showed similar metabolite clustering to the sham animals
(Figure 2B). This was confirmed by an OPLS-DA analysis, which
generated amodel comparing the total metabolites in all the brain
areas between sham and acoustic trauma animals (PC1: R2X =
0.21, R2Y = 0.0286, Q2Y = −0.0245; PC2: R2X = 0.112, R2Y
= 0.0354, Q2Y = −0.038). OPLS-DA visualized the clustering
samples within a group and the separation of two groups of
FIGURE 1 | Typical GC/MS chromatograms of extracts from brain tissue of a sham animal. The compounds were identified as: 1. Lactic Acid 2. Alanine
3. Oxalic acid 4. Valine 5. Urea 6. Phosphoric acid 7. Proline 8. Glycine 9. Serine 10. Threonine 11. Malic acid 12. Aspartic acid 13.γ-Aminobutanoic acid
14.Creatinine 15. Glutamic acid 16. Phenylalanine 17. N-Acetylaspartic acid 18. Hypoxanthine 19. Citric acid 20. Lysine 21. Tyrosine 22. Palmitic acid 23. Myo-Inositol
24. Oleic acid 25. Stearic acid 26. Arachidonic acid 27. Docosahexaenoic acid 28. Inosine 29. Glycerol monostearate 30. Cholesterol
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FIGURE 2 | PLS-DA score plot of different brain regions from sham (A) and acoustic trauma (B) groups. (A) sham (PC1: R2X = 0.344, R2Y = 0.0842, Q2 =
0.0726; PC2: R2X = 0.249, R2Y = 0.0525, Q2 = 0.0373; All 6 PCs: R2X (cum) = 0.84, R2Y (cum) = 0.381, Q2 (cum) = 0.286.); (B) acoustic trauma (PC1: R2X =
0.336, R2Y = 0.0759, Q2 = 0.0683; PC2: R2X = 0.307, R2Y = 0.0513, Q2 = 0.0407; All 6 PCs: R2X (cum) = 0.875, R2Y (cum) = 0. 384, Q2 (cum) = 0.325. AC,
auditory cortex; CB, cerebellum; IC, inferior colliculus; CN, cochlear nucleus; VCN, vestibular nucleus complex; SC, superior colliculus; CA1 and CA2 of the
hippocampus; DG, dentate gyrus; FC, frontal cortex; PC, perirhinal cortex; EC, entorhinal cortex.
samples. The closer clustering of samples indicates the more
similar composition of the detected variables, while the more
distant scattering of samples indicates the larger variation in the
composition of the detected variables. These results suggested
that, taking all brain regions together, the acoustic trauma and
sham animals could not be discriminated from one another.
However, when the metabolite profiles in individual areas
were analyzed using the OPLS-DA model, acoustic trauma
(purple dots in left panel, Figure 3) significantly shifted the
metabolite profile away from the sham animals (red dots in right
panel, Figure 3) in the AC (Predictive component: R2X = 0.194,
R2Y = 0.76, Q2Y = 0.45; Orthogonal component: R2X = 0.446;
All components: R2X(cum) = 0.64), IC (Predictive component:
R2X= 0.293, R2Y= 0.978, Q2Y= 0.702; Orthogonal component
1: R2X = 0.417; All components: R2X (cum) = 0.905), SC
(Predictive component: R2X= 0.238, R2Y= 0.791, Q2Y= 0.691;
Orthogonal component: R2X = 0.562; All components: R2X
(cum) = 0.8), VNC (Predictive component: R2X = 0.403,
R2Y = 0.779, Q2Y = 0.445; Orthogonal component: R2X =
0.389; All components: R2X (cum) = 0.792) and CB (Predictive
component: R2X= 0.152, R2Y= 0.973, Q2Y= 0.68; Orthogonal
component 1: R2X= 0.364; All components: R2X (cum)= 0.927)
(Figure 3, left panel). In addition, the discriminant molecules or
potential markers for the two groups could be visualized in an
S-plot (Figure 3, right panel).The X- and Y-axes are p[1] and
p(corr)[1] vectors of the predictive component, which describes
the magnitude and reliability of each variable in X, respectively.
X-variables situated far out on the tips of the wings of the S
shape represent high model influence with high reliability and
are of relevance in the search for biomarkers. Further analysis of
the relative concentrations using Student’s t-tests revealed a total
of 17 differentially changed molecules associated with acoustic
trauma (Figure 4). These included urea, amino acids, fatty acids,
sugar acids, nucleosides and organic acids and the changes were
region-specific. For example, the level of GABA was significantly
increased only in the AC, while an increase in glutamic acid was
observed in both the CB and VNC (Figure 4).
Based on the discriminant molecules identified, a metabolic
pathway analysis was conducted by entering the discriminant
molecules into the available online Metaboanalyst programme.
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FIGURE 3 | OPLS-DA and S-plot analysis comparing the OPLSDA scores between sham and acoustic trauma animals in different brain regions. Left
panel, OPLSDA scores plots, red dots: Sham, purple dots: Acoustic trauma; Right panel, S-plots. (A,B) AC (Predictive component: R2X = 0.194, R2Y = 0.76, Q2 =
0.45; Orthogonal component 1: R2X = 0.446; All components: R2X (cum) = 0.64); (C,D) CB (Predictive component: R2X = 0.152, R2Y = 0.973, Q2 = 0.68;
Orthogonal component 1: R2X = 0.364; All components: R2X (cum) = 0.927); (E,F) IC (Predictive component: R2X = 0.293, R2Y = 0.978, Q2 = 0.702; Orthogonal
component 1: R2X = 0.417; All components: R2X (cum) = 0.905); (G,H) SC (Predictive component: R2X = 0.238, R2Y = 0.791, Q2 = 0.691; Orthogonal
component: R2X = 0.562; All components: R2X (cum) = 0.8); (I,J) VNC(Predictive component: R2X = 0.403, R2Y = 0.779, Q2 = 0.445; Orthogonal component: R2X
= 0.389; All components: R2X (cum) = 0.792). AC, auditory cortex; CB, cerebellum; IC, inferior colliculus; CN, cochlear nucleus; VCN, vestibular nucleus complex.
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FIGURE 4 | Relative abundance (RA) of the discriminant metabolites in different brain regions of sham (blue) and acoustic trauma (red) groups.
*p < 0.05; **p < 0.01. AC, auditory cortex; CB, cerebellum; IC, inferior colliculus; CN, cochlear nucleus; VCN, vestibular nucleus complex.
The pathway impact analysis suggested that acoustic trauma
produced a significant impact on a number of metabolic
pathways. A set of 4 pathways was selected. These included
glutathione metabolism, alanine aspartate and glutamate
metabolism, arginine and proline metabolism and glycine,
serine and threonine metabolism (Figure 5A) The enrichment
overview of the network ranked the acoustic trauma-perturbed
metabolite sets by their respective fold enrichment, which
provides information on the significant and coordinated changes
in metabolites. As shown in Figure 5B, the identified metabolites
were involved in multiple pathways and the p-values indicated
whether a particular metabolite set was represented more
than expected by chance. The most enriched pathway was the
glutathione metabolism pathway.
Further analysis on the correlation was conducted based
on the 88 identified metabolites from both sham and acoustic
trauma animals to further study the association and interaction
patterns between metabolites. Nodes represent the identified
metabolites and edges indicate significant correlation between
nodes. As can be seen in Figure 6, some nodes had more
connections with others, while other nodes had fewer links. There
were also nodes that were clustered together with a short distance
between them. Based on the degree (k) of each node, the top
10 highly connected metabolites were considered as hubs of the
network and these metabolites are involved in purine metabolism
(green circle), glutamate metabolism (blue circle) and arginine
metabolism (red circle) (Figure 6).
DISCUSSION
We reported here that acoustic trauma in rats caused a significant
shift in metabolite profiles in a number of brain areas. These
included both auditory and non-auditory areas. In addition,
acoustic trauma imposed a significant impact on a number
of metabolic pathways including those involved in purine,
glutamate and arginine metabolism.
To our knowledge, this is the first study that has used
metabolomics to profile brain metabolite changes in relation
to acoustic trauma. Over the last decade, metabolomics has
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FIGURE 5 | Overview of the impact of acoustic trauma on brain metabolites. (A) The pathway impact of acoustic trauma on metabolites. The y axis shows the
p-values and the x axis, the pathway impact values; the node color is based on its p-value and the node size reflects the pathway impact values. (B) The enrichment
overview of the pathway-associated metabolite sets perturbed by acoustic trauma.
become one of the major “omics” tools in understanding disease
pathology, identifying biomarkers, improving diagnosis and
developing personalized therapy (see Botas et al., 2015; Shah
et al., 2015 for reviews). In addition, brain metabolomics has
been used to understand the pathology and identify potential
markers for neurodegenerative diseases in both animal models
and human post-mortem tissues due to the fact that metabolic
changes in the brain are more likely to reflect disease etiology
than those in peripheral biofluids (Pears et al., 2005; Salek
et al., 2010; Graham et al., 2013; Fauvelle et al., 2015; Xu
et al., 2016). In the present study, 107 small molecules were
detected from 12 different brain regions and 88 of them were
authentically identified. The metabolic models developed were
able to accurately distinguish acoustic trauma animals from sham
controls in selected brain regions. The predictive accuracies
of these models ranged from 45 to 70.2%, which suggests a
reasonably good level of predictive power when compared with
41% accuracy in predicting Batten’s disease (Pears et al., 2005)
and 54–60% in predicting Alzheimer’s disease using animal brain
tissues (Salek et al., 2010), although not as good as that reported
using human post-mortem brain tissues for Alzheimer’s disease
(91–97%) (Graham et al., 2013).
Although it has neither been extensively studied and nor
is well understood, hearing loss and/or tinnitus has been
linked to changes in the homeostasis of body metabolism.
For example, it has long been noticed that chronic kidney
disease (Ikeda et al., 1987; Govender et al., 2013; Renda et al.,
2015) or diabetes (Kurien et al., 1989; Sasso et al., 1999)
that cause metabolic disturbances are often accompanied by
impaired hearing. Moreover, metabolite changes have been
associated with presbycusis (Profant et al., 2013), congenital
sensorineural hearing loss (Wu et al., 2016) and idiopathic
FIGURE 6 | Correlation network analysis of differential metabolites.
(1) N-Acetylaspartate, (2) Glutamic acid, (3) γ-aminobutyric acid, (4) Cysteine,
(5) Glycine, (6) Serine, (7) Pyroglutamic acid, (8) Aspartic acid, (9) Ornithine,
(10) Glyceric acid, (11) Myo-Inositol, (12) Urea, (13) Citric acid, (14)
Hypoxanthine, (15) Xanthine, (16) 3-Hydroxybutyric acid, (17) Oleic acid, (18)
Stearic acid, (19) Palmitic acid, (20) Arachidonic acid, (21) Inosine.
sudden sensorineural hearing loss (Dinc et al., 2016). In the
present study, among the 88 small molecules identified, 17 of
them had their levels significantly altered by acoustic trauma in
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at least one of the brain regions examined. These metabolites
are predominantly involved in amino acid metabolism, the urea
cycle as well as oxidation-reduction reactions. The long-term
effects of acoustic trauma on amino acid levels in auditory
brain regions have been investigated in a previous study, which
reported a significant increase in glutamate, GABA and aspartate
and a decrease in taurine (Godfrey et al., 2012). This is in a
general agreement with the present results except that our study
extended the finding into some non-auditory areas, such as the
CB and VNC, which may suggest a more widespread effect of
acoustic trauma in disturbing the balance between excitatory and
inhibitory amino acids. It is of note that Bauer et al. (2013) have
recently reported a link between the paraflocculus and tinnitus
perception in rats. Using the network impact analysis, glutathione
metabolism, the ammonia cycle and the urea cycle appeared to be
affected the most by the acoustic trauma. While glutathione is an
important antioxidant in cells, ammonia and urea are crucial to
amino acid synthesis and metabolism. Studies have shown that
a low protein diet resulting in a reduced cochlear glutathione
level increased cisplatin-induced ototoxicity (Lautermann et al.,
1995) and N-acetylcysteine (NAC), a precursor of glutathione,
attenuated hearing loss in a number of animal models (Wu et al.,
2010; Ding et al., 2016). Urea tests have long been used to aid
the diagnosis of vestibular and hearing impairment in patients
with Ménière’s disease (Babin and Bumsted, 1980; Imoto and
Stahle, 1983) and urea has also been used to temporarily improve
hearing in these patients (Angelborg et al., 1977). This effect was
thought to be partially due to the changes in perilymph osmolality
caused by urea (Juhn et al., 1979). Interestingly, the urea cycle
was altered in multiple brain regions in neurodegenerative
diseases such as Huntington’s disease (Patassini et al., 2015) and
Alzheimer’s disease (Xu et al., 2016), which suggests that brain
urea metabolism may play an important role in maintaining
neuronal function. Therefore, the altered brain glutathione and
urea metabolism observed in the present study may contribute to
acoustic trauma-induced hearing loss. It is worthmentioning that
although hearing levels were not measured prior to sacrificing
the animals in this study, we found in a separate study that
hearing loss had recovered at 6 months following the same
acoustic trauma exposure in rats (Zheng et al., 2015). Therefore,
it is conceivable that hearing loss had also recovered by 6
months in the present study, hence, the metabolic changes were
not directly attributable to hearing loss. It has been shown
that acoustic trauma has variable effects on ABR thresholds
in individual animals and the degree of hearing loss is not
correlated with tinnitus perception in these mice (Longenecker
et al., 2014; Longenecker and Galazyuk, 2016), which suggests
that the impact of acoustic trauma on the auditory system is not
limited to the peripheral damage, but involves damage to the
higher centers of the brain. Our results are in agreement with this
view and extend the evidence to include changes in metabolic
pathways. In addition, the present study investigated metabolic
changes in both auditory and non-auditory brain regions, which
may provide insights into the wide range of emotional and
cognitive impairments associated with acoustic trauma.
One of the limitations that prevented the current results being
directly linked to tinnitus is the lack of behavioral evidence of
tinnitus in these animals at the time of sample collection. As
described in our previous publication (Zheng et al., 2012), the
acoustic trauma-exposed animals developed tinnitus at 1 month
post-exposure, which was confirmed by the conditioned lick
suppression test. Both sham and exposed animals then received
saline and 3 different doses of L-baclofen treatment and were
tested for their behavioral signs of tinnitus after each treatment.
At the conclusion of the experiment, the exposed animals
did not have significant behavioral signs of tinnitus compared
with sham animals. Therefore, it is not possible to relate the
metabolic changes to tinnitus in this study, only to acoustic
trauma. However, it is reasonable to attribute the changes to
acoustic trauma since both the sham and acoustic trauma animals
received exactly the same L-baclofen treatment. Nonetheless, this
is the first study using the powerful metabolomics technique
to investigate brain metabolite shifts in relation to acoustic
trauma at the network level. This is a proof of concept study
that established a method sensitive enough to detect metabolic
changes in discrete brain regions.
CONCLUSIONS
In this study, we optimized a metabolomics approach to predict
acoustic trauma using brain tissues, with comparable accuracy
to studies predicting other neurodegenerative diseases in animal
models (Pears et al., 2005; Salek et al., 2010). Further studies are
needed to identify brain metabolic changes specifically related to
tinnitus and to correlate changes in the brain with those in the
blood for future clinical translation. This will provide a powerful
tool toward a better understanding of tinnitus heterogeneity and
the development of personalized therapies.
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